• SENSEX 74,315.61
    1,533.72 (+2.11%)
  • BANKNIFTY 55,810.50
    494.50 (+0.89%)
  • Reliance Industries
    1,223.30 1,611.20(%)
  • NSE
    1,777.00 1,878.00(%)
  • TCS
    2,386.70 3,336.70(%)
  • HCL Technologies
    1,376.00 1,770.00(%)
  • HDFC Bank
    728.55 1,020.35(%)
  • Infosys
    1,126.40 1,727.85(%)
  • Indian Hotels Co
    752.50 757.10(%)
  • Gallantt Ispat L
    648.45 946.70(%)
  • ICICI Bank
    1,395.00 1,479.90(%)
  • NMDC
    70.56 70.15(%)
  • Billionbrains
    200.85 227.00(%)
  • Axis Bank
    1,294.40 1,418.30(%)
  • Netweb Technol.
    4,666.00 2,942.45(%)
  • Bajaj Finance
    975.00 1,177.60(%)
  • HDB FINANC SER
    536.65 536.65(%)
  • Bharti Airtel
    1,871.20 2,174.70(%)
  • SS Retail
    741.55 603.00(%)
  • Eternal
    324.35 368.40(%)
  • Kotak Mah. Bank
    448.85 452.98(%)
  • MV Electrosystems
    918.00 510.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Akums Drugs & Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 34484.0
  • ISIN : INE09XN01023
749.80 -20 (-2.62%)
  • As on 15 Oct 2026 (EOD)

  • Today’s Low

    743.20

  • Today’s High

    769.95

  • Open

    769.95

  • Perv Close

    769.95

  • 52W Low

    409.30

  • 52W High

    838.80

Key Indicators

  • P/E(TTM)

    101.26

  • Mar.Cap (₹Cr.)

    11,801.40

  • Div & Yield %

    0.39

  • Book Value(₹)

    154.29

  • Debt-Equity Ratio

    -2.62

  • AGM Date

    15-Oct-2026

  • EPS

    7.40

  • P/E Ratio

    101.26

Financials Ratios

  • Debt-Equity Ratio

    0.83

  • Mar.Cap (₹Cr.)

    11,801.40

  • RONW (%)

    -2.22

  • ROCE (%)

    1.24

Score Board

  • Equity (₹ in Cr.)

    31.48

  • BV (₹)

    154.30

  • Sales( ₹ in Cr.)

    1,348.74

  • NP (in Cr.)

    116.52

  • NP Var(%)

    -26.0

  • Div%

    150.0

  • CPS (₹)

    10.30

  • EPS (₹)

    7.40

  • Traded Value (₹ in Lakhs)

    11,793.53

  • 52 Week High

    838.80

  • 52 Week Low

    409.30

  • Price BSE

    749.0

  • Price NSE

    750.00

  • Market Capital( in Cr.)

    11,793.53

  • P/C Ratio

    72.80

  • P/E Ratio

    101.20

  • Price Vs.BV

    7.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,348.74 1,311.78 1,444.12 1,286.83 1,162.06 837.44
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,348.74 1,311.78 1,444.12 1,286.83 1,162.06 837.44
Other Income 112.97 124.19 94.12 96.15 58.48 54.51
Stock Adjustments 3.26 10.05 -6.44 3.06 18.45 -10.64
Total Income 1,464.97 1,446.02 1,531.80 1,386.04 1,238.99 881.31
EXPENDITURE :            
Raw Materials 830.34 811.06 867.24 791.21 786.51 513.05
Power and Fuel Cost 49.64 45.36 42.40 42.04 36.25 28.64
Employee Cost 217.99 201.74 175.28 147.30 136.37 122.65
Other Manufacturing Expenses 68.15 68.18 62.69 42.04 62.62 51.89
Selling and Administration Expenses 42.19 25.73 31.90 22.33 16.82 13.80
Miscellaneous Expenses 52.73 31.27 404.21 147.63 503.99 319.56
Employee Benefit Expenses 217.99 201.74 175.28 147.30 136.37 122.65
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,261.05 1,183.34 1,583.73 1,192.54 1,542.55 1,049.59
Operating Profit 203.91 262.69 -51.93 193.50 -303.56 -168.28
Interest 10.04 15.31 18.31 13.18 3.65 0.82
Gross Profit 193.87 247.38 -70.24 180.32 -307.21 -169.10
Depreciation 45.50 39.55 32.69 30.00 27.76 26.10
Profit Before Tax 148.37 207.83 -102.93 150.32 -334.97 -195.20
Current Tax 36.40 49.66 62.52 41.00 0.34 6.40
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.32 -2.83 0.00 -16.11 46.46 -56.17
Reported Net Profit 111.64 161.00 -165.45 125.43 -381.78 -145.43
Extraordinary Items -4.88 2.61 -7.98 -105.11 0.99 -255.75
Adjusted Net Profit 116.52 158.39 -157.47 230.54 -382.77 110.32
Adjustment below Net Profit 0.47 861.44 -2.18 0.00 -11.62 0.16
P & L Balance brought forward 1,317.83 295.39 463.02 351.36 744.75 890.02
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 13.77 0.00 0.00
P & L Balance carried down 1,429.93 1,317.83 295.39 463.02 351.36 744.75
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 150.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 3.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 7.29 10.52 -11.56 8.77 -53.37 -1,117.82
Earnings Per Share(Adj)-Unit Curr 7.29 10.52 - - - -
Book Value 158.56 150.57 10.06 21.77 25.94 4,358.55
Book Value(Adj)-Unit Curr 158.56 150.57 - - - -

Shareholding Pattern

  • Promoter Group

    75.26%

  • Public Share Holding

    22.01%

  • Custodian

    2.73%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 54,255,380 34.47 54,255,380 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 64,200,000 40.79 64,200,000 1
Others 0 0.00 0 0
Sub Total 118,455,380 75.26 118,455,380 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,082,728 4.50 7,082,728 91
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 184,794 0.12 184,794 2
Mutual Funds / UTI 11,924,939 7.58 11,924,939 12
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 5,336,687 3.39 5,336,687 25
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 24,529,148 15.58 24,529,148 130
2] Non Institution
Bodies Corporate 947,834 0.60 947,834 376
Clearing Members 75,993 0.05 75,993 17
Directors of their Relatives 42 0.00 42 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 424,106 0.27 424,106 1,006
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 328,993 0.21 328,993 1,643
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 488,500 0.31 488,500 1
Individuals holding nominal share capital up to Rs. 1 lakh 7,715,434 4.90 7,715,434 64,383
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 25,052 0.02 25,052 4
Others 794 0.00 794 2
Sub Total 10,117,530 6.43 10,117,530 67,483
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 4,291,930 2.73 4,291,930 1
Total Shares held by Custodians and against which Depository Receipts have been issued 4,291,930 2.73 4,291,930 1
Grand Total ( A + B + C ) 157,393,988 100.00 157,393,988 67,618

Company Background

Akums Drugs & Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Akums Drugs & Pharmaceuticals Ltd
  • BSE Code : 34484.0
  • ISIN : INE09XN01023

  • Incorporation Year

    2004

  • Registered Office

    304 Mohan Place LSC Saraswati
    Vihar, Delhi,
    Delhi-110034

  • Telephone

    +91 11 6904 1000

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    DHARAMVIR MALIK

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Akums Drugs & Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Akums Drugs 749.30 1,461.70 1,348.74 105.68 6.48
Abbott India 26,068.45 7,217.19 6,929.05 34.31 43.78
Astrazeneca Phar 5,922.60 2,304.07 2,275.58 87.29 27.86
Glaxosmi. Pharma 2,523.00 3,932.76 3,790.20 40.30 58.17
Novartis India 1,937.30 393.10 354.33 48.92 15.94
Cipla 1,333.70 20,102.60 18,979.95 35.05 13.88
Bliss GVS Pharma 655.95 773.53 729.81 60.96 12.51
Amrutanjan Healt 506.40 520.13 502.55 27.12 24.16
Fermenta Biotec. 486.65 474.15 450.25 22.72 18.77
Guj. Themis Bio. 370.70 168.25 165.82 99.12 18.05
Ambalal Sarabhai 38.15 19.52 3.94 70.65 6.77